对肥胖和非肥胖成年人的认知功能和反应时间进行比较研究
Hacı Ömer Yılmaz1, Kezban Şahin1, Hilal Ayvaz2
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Bandırma Onyedi Eylul University, Balıkesir, Türkiye.
Neurological research
|February 4, 2025
概括
肥胖与成年人的认知功能较差和反应时间较慢有关. 这项研究发现,肥胖个体在认知测试中表现较差,视觉和听觉反应延迟.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 人体生理学 人体生理学
背景情况:
- 肥胖是一个日益严重的全球健康问题.
- 它对认知功能和反应时间的影响需要进一步调查.
- 现有的研究表明潜在的负面关联.
研究的目的:
- 研究肥胖对认知表现的影响.
- 评估肥胖对成年人视觉和听觉反应时间的影响.
主要方法:
- 研究了100名参与者 (50名肥胖者,50名正常体重者).
- 用蒙特利尔认知评估 (MoCA) 评估认知功能.
- 使用简单反应时间任务 (SRTT) 测量视觉和听觉反应时间.
主要成果:
- 肥胖的参与者与正常体重的参与者相比,MoCA得分明显较低.
- 肥胖个体表现出明显更长的听觉和视觉反应时间.
- 肥胖独立地与认知得分下降和反应时间延迟有关.
结论:
- 肥胖与认知功能受损和反应时间减慢有关.
- 这些发现凸显了肥胖对神经和精神运动表现的广泛影响.
- 需要进一步的研究来了解潜在的机制.
更多相关视频
相关概念视频
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients
352
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
352
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
310
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310


